Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-27

FDA Approved: METHYLPREDNISOLONE ACETATE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved the original application for methylprednisolone acetate from Sagent Pharmaceuticals, enabling a generic topical corticosteroid product. The app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylprednisolone acetate (Methylprednisolone acetate)

Snippet

ORIG AP for METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE)